NS-102 is a selective kainate (GluK2) receptor antagonist. NS-102 is a potent GluR6/7 receptor antagonist .In VitroCombination of NS-102 (10 μM) and GYKI 52466 (30 μM) preventes full loss of compound action potentials (CAPs) during oxygen and glucose deprivation (OGD) and increases CAP area recovery. MCE has not independently confirmed the accuracy of these methods. They are for reference only.In VivoNS-102 (20, 40 or 80 μmol/litre ; in the hippocampal CA3 region) significantly reduces Sevoflurane-induced hyperactivities . MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:Solid.
Specifications and Purity: ≥98%
Molecular Formula: C12H11N3O4
Molecular Weight: 261.23
PubChem CID: 4461601
Isomeric SMILES: C1CCC2=C3C(=CC(=C2C1)[N+](=O)[O-])C(=C(N3)O)N=O
- UPC:
- 85101605
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- N649957-10mg
- CAS:
- 136623-01-3
- Product Size:
- 10mg
akash.verma@cenmed.com
(732) 447-1115





